Cargando…

Pulmonary Lobectomy After COVID-19

Concomitant coronavirus disease 19 (COVID-19) is a major risk factor for complications in any type of surgical procedure, especially in thoracic surgery, were the primary organ involved, the lung, is manipulated to perform parenchymal resection. However, it is not clear whether previous infection fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Testori, Alberto, Perroni, Gianluca, Voulaz, Emanuele, Crepaldi, Alessandro, Alloisio, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The Society of Thoracic Surgeons Published by Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518286/
https://www.ncbi.nlm.nih.gov/pubmed/32987024
http://dx.doi.org/10.1016/j.athoracsur.2020.08.004
Descripción
Sumario:Concomitant coronavirus disease 19 (COVID-19) is a major risk factor for complications in any type of surgical procedure, especially in thoracic surgery, were the primary organ involved, the lung, is manipulated to perform parenchymal resection. However, it is not clear whether previous infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to increased morbidity and mortality for subsequent procedures once radiologic resolution is achieved. We report a young patient with lung cancer who successfully underwent a right upper lobectomy for primary adenocarcinoma by video-assisted thoracoscopic surgery with no complication in the early postoperative phase.